Geneos Wealth Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.68K | Sell |
363
-21
| -5% | -$502 | ﹤0.01% | 2374 |
|
|
2025
Q1 | $25.7K | Buy |
384
+287
| +296% | +$19.2K | ﹤0.01% | 2226 |
|
|
2024
Q4 | $1.83K | Sell |
97
-65
| -40% | -$1.22K | ﹤0.01% | 2629 |
|
|
2024
Q3 | $2.44K | Buy |
+162
| New | +$2.44K | ﹤0.01% | 2254 |
|
|
2023
Q4 | – | Sell |
-150
| Closed | -$4.6K | – | 2152 |
|
|
2023
Q3 | $4.6K | Hold |
150
| – | – | ﹤0.01% | 1769 |
|
|
2023
Q2 | $6.01K | Hold |
150
| – | – | ﹤0.01% | 1696 |
|
|
2023
Q1 | $6.12K | Hold |
150
| – | – | ﹤0.01% | 1681 |
|
|
2022
Q4 | $5.79K | Hold |
150
| – | – | ﹤0.01% | 1673 |
|
|
2022
Q3 | $7K | Hold |
150
| – | – | ﹤0.01% | 1616 |
|
|
2022
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 2038 |
|
|
2022
Q1 | $11K | Hold |
150
| – | – | ﹤0.01% | 2059 |
|
|
2021
Q4 | $9K | Hold |
150
| – | – | ﹤0.01% | 2224 |
|
|
2021
Q3 | $8K | Hold |
150
| – | – | ﹤0.01% | 2309 |
|
|
2021
Q2 | $8K | Hold |
150
| – | – | ﹤0.01% | 2291 |
|
|
2021
Q1 | $9K | Hold |
150
| – | – | ﹤0.01% | 2431 |
|
|
2020
Q4 | $10K | Hold |
150
| – | – | ﹤0.01% | 2223 |
|
|
2020
Q3 | $8K | Hold |
150
| – | – | ﹤0.01% | 2034 |
|
|
2020
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 2097 |
|
|
2020
Q1 | $4K | Hold |
150
| – | – | ﹤0.01% | 2115 |
|
|
2019
Q4 | $6K | Hold |
150
| – | – | ﹤0.01% | 2151 |
|
|
2019
Q3 | $6K | Hold |
150
| – | – | ﹤0.01% | 2067 |
|
|
2019
Q2 | $6K | Hold |
150
| – | – | ﹤0.01% | 2080 |
|
|
2019
Q1 | $5K | Buy |
+150
| New | +$5K | ﹤0.01% | 2050 |
|
|
2017
Q1 | – | Sell |
-46
| Closed | -$1K | – | 2116 |
|
|
2016
Q4 | $1K | Hold |
46
| – | – | ﹤0.01% | 1981 |
|
|
2016
Q3 | $1K | Buy |
+46
| New | +$1K | ﹤0.01% | 1907 |
|